Pemafibrate decreases triglycerides and small, dense LDL, but increases LDL-C depending on baseline triglycerides and LDL-C in type 2 diabetes patients with hypertriglyceridemia: an observational study

Komiya, I; Yamamoto, A; Sunakawa, S; Wakugami, T

Komiya, I (corresponding author), Okinawa Med Hosp, Dept Internal Med, 2310 Tsuhako Nishihara, Nanjo, Okinawa 9011414, Japan.; Komiya, I (corresponding author), Med Plaza Daido Cent, Dept Diabet & Endocrinol, 123 Daido, Naha, Okinawa 9020066, Japan.

LIPIDS IN HEALTH AND DISEASE, 2021; 20 (1):

Abstract

Background Pemafibrate, a selective PPAR alpha modulator, has the beneficial effects on serum triglycerides (TGs) and very low density lipoprotein (VL......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索